Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02229201Phase 1Completed
Phase 1, randomised, open-label trial of propofol in brain tumor (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Interleukin 10 plasma concentrations at 48 hours. Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02229201.